Neoquadruple Induction With Antithymocyte Globulin/Azathioprine/Cyclosporine/Prednisolone in Simultaneous Pancreas and Kidney Transplant Recipients: 8.5-Year Results
Transplantation Proceedings, ISSN: 0041-1345, Vol: 37, Issue: 4, Page: 1815-1817
2005
- 1Citations
- 11Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Ten years ago therapy with antithymocyte globulin or OKT3, azathioprine, cyclosporine, and prednisolone was the most common induction treatment for simultaneous pancreas/ kidney (SPK) recipients. Although immunosuppression was started after surgery, there was a high incidence of acute rejection episodes. In 1995, we modified the application of antithymocyte globulin and prednisolone by starting prior to reperfusion.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0041134505001892; http://dx.doi.org/10.1016/j.transproceed.2005.02.072; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=20344382531&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/15919475; https://linkinghub.elsevier.com/retrieve/pii/S0041134505001892; https://dx.doi.org/10.1016/j.transproceed.2005.02.072
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know